Recent advances of clinical managements of primary ciliary dyskinesia

  • WEI Jianhua
Expand
  • Department of Respiration, Children's Hospital of Chongqing Medical University, Ministry of Education Key Laboratory of Child Development and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Chongqing 400014, China

Online published: 2019-02-26

Abstract

Primary ciliary dyskinesia syndrome (PCD) is a rare genetic disease with high heterogeneity, the diagnostic strategy of PCD is becoming more and more complete. However, the lack of prompt clinical managements for many patients resulted in severe consequences. This article will review on the recent advances of clinical managements of upper and lower respiratory tract and other systems to explore unified and prompt management strategy. In addition, azithromycin and gene editing are promising treatment approaches.

Cite this article

WEI Jianhua . Recent advances of clinical managements of primary ciliary dyskinesia[J]. Journal of Clinical Pediatrics, 2019 , 37(2) : 144 . DOI: 10.3969/j.issn.1000-3606.2019.02.017

Outlines

/